NinePointTwo Capital’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-17,174	Closed	-$120K	–	260
2023 Q2	$120K	Hold	17,174	–	–	0.05%	228
2023 Q1	$143K	Hold	17,174	–	–	0.05%	245
2022 Q4	$197K	Buy	+17,174	New	+$197K	0.08%	124